OWC Pharmaceutical Research Corp. (OWCP) financial statements (2020 and earlier)

Company profile

Business Address 2 BEN GURION ST.
RAMAT GAN, 5257334
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 3,464971472357
Cash and cash equivalents 3,464971472357
Other current assets 52749 
Other undisclosed current assets    50
Total current assets: 3,5161,045482408
Noncurrent Assets
Property, plant and equipment 37161523
Total noncurrent assets: 37161523
TOTAL ASSETS: 3,5531,061497430
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 9865825
Accounts payable 98658 
Accrued liabilities    25
Debt    3
Estimated litigation liability 15   
Deferred revenue and credits100100 
Customer advances and deposits  50
Other liabilities 24010638 
Other undisclosed current liabilities 85  30
Total current liabilities: 438270146108
Noncurrent Liabilities
Other undisclosed noncurrent liabilities 10,329 250 
Total noncurrent liabilities: 10,329 250 
Total liabilities: 10,767270396108
Temporary equity, carrying amount 2,226   
Stockholders' equity
Stockholders' equity attributable to parent, including: (9,440)791101323
Common stock 2111
Common stock, share subscribed but unissued, subscriptions receivable (239)(344)(652)652
Additional paid in capital 18,13716,16811,0378,534
Accumulated other comprehensive income (loss) 366(11)
Accumulated deficit (27,222)(14,517)(9,836)(7,549)
Other undisclosed stockholders' equity attributable to parent (121)(525)(455)(1,303)
Total stockholders' equity: (9,440)791101323
TOTAL LIABILITIES AND EQUITY: 3,5531,061497430

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues   50 
Cost of revenue
(Financial Services Costs)
  (5)(189) 
Gross profit:  (5)(139) 
Operating expenses (4,296)4,5542,148(1,651)
Other undisclosed operating loss  (9,103)(4,107) 
Operating loss: (4,296)(4,554)(2,098)(1,651)
Nonoperating income
(Other Nonoperating income)
 3   
Interest and debt expense    0
Net loss: (4,293)(4,554)(2,098)(1,651)
Other undisclosed net loss attributable to parent (5,965)(5)(189)(4)
Net loss attributable to parent: (10,258)(4,558)(2,287)(1,655)
Preferred stock dividends and other adjustments (2,447)   
Net loss available to common stockholders, diluted: (12,705)(4,558)(2,287)(1,655)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss: (4,293)(4,554)(2,098)(1,651)
Other comprehensive income (loss) (3)02,270(1,672)
Other undisclosed comprehensive income 14,557   
Comprehensive income (loss), net of tax, attributable to parent: 10,261(4,553)172(3,323)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: